AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $1.68M invested in Akari Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$83K | |
| 2 | +$33K | |
| 3 | +$15K | |
| 4 |
Millennium Management
New York
|
+$14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3K |
Top Sellers
| 1 | -$25K | |
| 2 | -$20K | |
| 3 | -$7K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$478 |
| 5 |
Renaissance Technologies
New York
|
-$300 |